Ikarian Capital’s Biohaven BHVN Stock Holding History

Ikarian Capital’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.49M	Buy	412,481 +200,000	+94%	+$2.19M	0.28%	77
2025 Q4	$2.4M	Buy	+212,481	New	+$2.63M	0.19%	94
2023 Q4	–	Sell	-106,138	Closed	-$2.76M	–	144
2023 Q3	$2.76M	Sell	106,138 -321,279	-75%	-$6.68M	0.33%	69
2023 Q2	$10.2M	Buy	427,417 +25,091	+6%	+$432K	1.63%	21
2023 Q1	$5.5M	Sell	402,326 -435,174	-52%	-$6.93M	1.25%	26
2022 Q4	$11.6M	Buy	+837,500	New	+$11.8M	2.8%	8

Other funds holding BHVN

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IAM

Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

RPSM

Royalty Pharma Sub-Manager New York $173M AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ikarian Capital's BHVN Position: Q1 2026 in Review

Ikarian Capital increased its Biohaven (BHVN) stake by 94% in Q1 2026, buying an estimated $2.19M and bringing the position to 412,481 shares worth $3.49M. The position accounts for 0.28% of the portfolio, ranked #77.

Ikarian Capital first reported a position in BHVN in Q4 2022 and has held it in 6 quarters since. The position peaked at $11.6M in Q4 2022. 275 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

Ikarian Capital held 412,481 shares of Biohaven worth $3.49M as of Q1 2026.
Ikarian Capital bought 200,000 Biohaven shares in Q1 2026, an estimated $2.19M.
Biohaven made up 0.28% of Ikarian Capital's portfolio in Q1 2026, its #77 holding.
Ikarian Capital first reported a position in Biohaven in Q4 2022 and has held it in 6 quarters since.
Ikarian Capital's Biohaven position peaked at $11.6M in Q4 2022.
275 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on Ikarian Capital's 13F filing for Q1 2026, filed 15 May 2026.